What is Belotero?

BELOTERO offers a comprehensive collection of hyaluronic acid fillers that deliver predictable and natural-looking results1 which respond to the individual needs of each patient. Take a closer look at the BELOTERO brand and its entire product collection to discover the right treatment for your patients needs.

Why Belotero?

The BELOTERO portfolio has seven products that are designed to be used in combination for facial rejuvenation. Each product has its own characteristics and intended use.

The BELOTERO collection is versatile enough to address multiple areas of concern including lip volumisation, softening fine lines, smoothing contours and restoring structure.

Some of the benefits of BELOTERO are:

  • Natural-looking results1
  • Predictable and harmonious results for high patient satisfaction and trust2
  • Established safety profile3

Mode Of Action

The BELOTERO difference is the combination of Cohesive Polydensified Matrix® (CPM®) technology for a lasting effect within the skin, while respecting facial movement providing natural-looking results.4

BELOTERO’s specific manufacturing process known as CPM® technology, results in different densities of HA, creating a combination of high and low-density zones. This allows the gel to ‘mimic’ tissue behaviour, to ensure optimal integration of the gel into the surrounding tissue. For you, this means that BELOTERO integrates seamlessly into the skin and stays intact for lasting effect.4


The BELOTERO ® range

BELOTERO Volume Instructions for Use (IFU). BELOTERO Balance Instructions for Use (IFU). BELOTERO Intense for Use (IFU). BELOTERO Soft Instructions for Use (IFU). BELOTERO Lips Shape for Use (IFU). BELOTERO Lips Contour for Use (IFU). BELOTERO Revive for Use (IFU).

For more information on the BELOTERO range visit ECADEMY

ECADEMY Find out more

Ecademy platform is intended for Doctors, Dentists, Nurses and Allied Healthcare Professionals who hold an independent prescribing qualification in the UK & Ireland. This website contains promotional content.

1. Micheels P, et al. J Drugs Dermatol. 2016 May 1;15(5):600-6.
2. Buntrock H, et al. Dermatol Surg. 2013 Jul;39(7):1097-105.
3. Kerscher M, et al. Clin Cosmet Investig Dermatol. 2017 Jun 29;10:239-247.
4. Micheels P, et al. J Clin Aesthet Dermatol. 2017 Jan;10(1):29-36.

Get in touch

Tell us who you are

  • Healthcare Professional
  • Member of the public

Advancing Medicine in Aesthetics.